Target intelligence / Profile preview

Cesium (Cs)

Target
Cs
Molecular classification
Alkali metal, Inorganic cation
01

Overview

Cesium is a chemical element and alkali metal that is not a canonical biological target but is highly significant in the fields of toxicology, oncology, and electrophysiology. In its ionic form (Cs+), cesium acts as a potent blocker of various potassium channels, most notably the delayed rectifier potassium current (IKr) and hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which can lead to severe cardiotoxicity and life-threatening arrhythmias such as Torsades de Pointes [10, 11]. While stable cesium chloride has been erroneously promoted in alternative medicine as a high pH cancer therapy, this practice is scientifically unsupported and associated with significant safety risks, including cardiac arrest and severe electrolyte imbalances [13, 14]. Conversely, radioactive isotopes such as Cesium-137 and Cesium-131 are established therapeutic agents in clinical oncology, utilized as radiation sources in brachytherapy to deliver targeted treatment to localized tumors in the prostate or cervix [2, 7]. The primary pharmacological intervention for cesium exposure or internal contamination is the administration of Prussian Blue (ferric hexacyanoferrate), which acts as a sequestering agent to facilitate the fecal excretion of the metal and reduce its biological half-life [8, 16].

Other names
Cesium-137Cesium-131Cesium chlorideCs+Radiocesium
02

Mechanism of action

Prussian Blue (ferric hexacyanoferrate) acts as an ion-exchange resin that traps cesium ions within its crystal lattice in the gastrointestinal tract, preventing absorption and interrupting enterohepatic circulation to enhance fecal elimination [16].

03

Biological functions

Blockade of voltage-gated potassium channels (IKr)Activation of glycine receptors (GlyR)Inhibition of hyperpolarization-activated cation currents (Ih)Competition with potassium ions for cellular transport
04

Disease associations

Radiation poisoningInternal radionuclide contaminationCancer (as a therapeutic isotope source)Cardiac arrhythmia (as a toxic effect)
05

Safety considerations

Prolonged QT intervalPolymorphic ventricular tachycardia (Torsades de Pointes)Severe hypokalemiaRadiation-induced hematopoietic suppressionGastrointestinal distress
06

Interacting drugs

Prussian Blue

2 more in the full profile.

07

Biomarkers

Whole blood cesium concentrationUrinary cesium excretion levelsElectrocardiographic QT interval duration

Beyond the preview

Go deeper on Cesium (Cs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cesium (Cs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call